BEIJING e NANJING, Cina–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) e Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (“NJCTTQ”) hanno annunciato che NTB003 (formerly BCG009), un farmaco candidato ini…
Author: Business Wire
Biocytogen und Nanjing Chia Tai Tianqing geben IND-Zulassung in China für gemeinsam entwickelten Anti-IGF-1R-Antikörper NTB003 (BCG009) bekannt
BEIJING und NANJING, China–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. („Biocytogen“, HKEX: 02315) und Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. („NJCTTQ“) melden, dass NTB003 (zuvor BCG009), ein gemeinsam entwickelter, in…
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)
BEIJING & NANJING, China–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) and Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (“NJCTTQ”) announced that NTB003 (formerly BCG009), a co-developed injectable d…
Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Blink Nourish Lubricating eye drops and Blink B…
Eye Health America Expands in Northeast Florida with the Addition of Schneider Eye & Wellness Center in Jacksonville Beach
JACKSONVILLE BEACH, Fla.–(BUSINESS WIRE)– #EyeCare–Eye Health America (EHA), a leading integrated eye care platform in the Southeastern United States, is proud to announce its newest partnership with Schneider Eye & Wellness Center, a respected …
Gore Launches 0.5 mL Silicone-Free GORE® IMPROJECT® Plunger for Ophthalmic Pre-Filled Syringes
NEWARK, Del.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (“Gore”), a global materials science company, recently announced the commercial launch of the 0.5 mL silicone-free* GORE® IMPROJECT® Syringe Plunger within its PharmBIO business. The new …
Tenpoint Therapeutics Ltd. Announces FDA Acceptance of New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia
LONDON & SEATTLE–(BUSINESS WIRE)– #BRIMOCHOL–Tenpoint Therapeutics Ltd. announces FDA acceptance of New Drug Application for BRIMOCHOL™ PF for the treatment of presbyopia
Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial Officer
LONDON & SEATTLE–(BUSINESS WIRE)– #CFO–Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial Officer.
Warby Parker Announces Participation in the Baird Global Consumer, Technology & Services Conference
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Baird Global Consumer, Technology & Services Confe…
Drug Device Combination Products Market Report 2025: Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler Forecasts to 2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthalmology), End User (Hospital, Home Care), and Region …
Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that To…
iVeena Announces IND Submission to the U.S. FDA for a Phase 2 Clinical Trial for Pediatric Myopia
SALT LAKE CITY–(BUSINESS WIRE)–iVeena Delivery Systems Inc. (“iVeena”), a biopharmaceutical company advancing IVMED-85 for the treatment of pediatric myopia, today announced the submission of an Investigational New Drug (IND) application to the U.S. …
Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
GENEVA–(BUSINESS WIRE)–Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
GENEVA–(BUSINESS WIRE)–Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
The Technology Platform Poised to Own the Online Eyewear Market — Now Available for Acquisition
BOSTON–(BUSINESS WIRE)– #AIForEyewear–Project Vision, a patented virtual eyewear fitting platform, is for sale and set to disrupt the $57B progressive lens market with military precision.
4Summers Hosting Epic, Summer Solstice, West Hollywood Fundraiser/Party To Raise Funds For Rare Eye Condition, Visual Snow
LOS ANGELES–(BUSINESS WIRE)– #CharityAuction–4Summers Hosts Summer Solstice, West Hollywood Fundraiser For Rare Eye Condition, Visual Snow. Local Artists Create One-of-a-Kind Sunglasses
FDA Approves Genentech’s Susvimo for Diabetic Retinopathy
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment…
Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chief Financial Officer Sam Eldessouky is scheduled to partic…
STAAR Surgical Announces Participation in Upcoming Investor Conferences
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will participate in the …